NOUVEAUX COMPOSES DE QUINOLONE UTILISES EN TANT QU'INHIBITEURS DE L'INTERACTION PROTEINE-PROTEINE DU DOMAINE BCL6 BTB ET/OU EN TANT QU'AGENTS DE DEGRADATION DE BCL6

• 收藏
• 分享

专利权人:

ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)

发明人:

CHAU, ANH MY,ISAAC, METHVIN

申请号：

CA3086362

公开号：

CA3086362A1

申请日:

2018.12.20

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present application relates to compounds of Formula I or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB and/or by degrading BCL6, such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/